Healthcare Summit

Ameera Shah

Dilip Jose

Dilip Jose is the Managing Director and CEO of Manipal Health Enterprises Pvt. Limited (Manipal Hospitals), an integrated healthcare services system and one of the largest hospitals network in India, with 37 facilities across 19 cities and over 10,500 beds.

He has more than 33 years of experience in various sectors and across functional areas. In healthcare, where he has spent the last 19 years, his previous assignment was as Group CEO of CARE Hospitals, managing a network of tertiary care facilities. Prior to that, he was the Regional Director with Fortis Healthcare, heading their operations in South India. Preceding that, he held leadership positions in the areas of Medical and Para-Medical education as well as tertiary healthcare delivery.

Before his move to the Healthcare sector, Mr Jose spent about 12 years in various roles in Corporate Finance and Strategy.

Prateek Verma

Prateek Verma heads the ePharmacy business at Tata 1mg, where he has been a driving force in the company’s growth from its early days to its position as a trusted healthcare platform with millions of users. He has built and scaled Product Management and Marketing teams at Tata 1mg, with his vision and expertise making a transformative impact on the healthcare industry.

Beyond his role at Tata 1mg, Prateek serves as a board member of 5C Network, a prominent digital diagnostics company, providing strategic guidance to further advance healthcare accessibility.
Prior to this journey, Prateek developed his expertise in scaling consumer products at Healthkart. He holds a degree from IIT Kanpur.

Rajagopal G

Raj is the Co-Founder & CEO of KITES Senior Care, a single specialty brand in geriatric care founded in Bangalore, South India in 2016. KITES Senior Care operates geriatric care centers and provides geriatric care at home & at senior living facilities. With 150+ beds under its management in three centers in Bengaluru & Hyderabad, KITES Senior Care has cared for over 4,500 elders since its inception both at their care facilities and at the residence of the elderly.

Raj commenced his healthcare journey as the CEO of Motherhood, a specialty in maternity care. He orchestrated a successful PE fund raise & a strategic acquisition which helped scale the brand from a single unit operations to multi-city multi-unit operations and its foray into treatment of infertility. 

Prior to his entrepreneurial journey, he also served as the Chief Executive of HCG Milann, leader in the space of reproductive medicine offering infertility treatment solutions & related research initiatives where he worked closely with the Board in formulating the growth strategies of the company and was responsible for its successful execution.

In the past, he has had the privilege of having worked with an eclectic mix of successful organisations Eastern Spices, AOL Time Warner, Cairn Energy India & HPCL where he had the opportunity to learn and contribute meaningfully at various levels.

His success stories include building/scaling brands, taking companies through Strategic M&A deals/PE fund raising, setting up of businesses (start-up/bootstrap) including scaling them. He strongly believes in effective teams to deliver organizational goals and hence strives to invest, build and grow high performing teams. Raj's strengths as a leader are in (a) Customer centric approach (b) People/Process/Value based Governance and (c) Sound Strategy with Execution.

Raj is a Fellow member of the Institute of Chartered Accountants of India, New Delhi, an alumnus of ISB, Hyderabad (AMP) and holds a bachelor’s degree in Mathematics from Madras University. He also serves on the boards' of a super specialty hospital and a healthcare focused strategic advisory firm. He is extremely passionate about mentoring start-ups & sharing knowledge with budding entrepreneurs.

Adarsh Narahari

Adarsh Narahari is the Managing Director of Primus Senior Living, pioneering luxury communities for seniors in India. His entrepreneurial spirit and passion led to the creation of Primus, a brand dedicated to providing affluent, independent seniors with the best living options.

To ensure Primus offers unparalleled senior living experiences, Adarsh travelled extensively, studying the finest global retirement communities. His efforts have earned numerous accolades, including the ET Business Excellence Award for “Excellence in Creating Senior Living Communities” (2020), Times Business Awards for “Best Senior Living Community in Bangalore” (2021) and “Best Senior Citizen Community” (2022).

Under Adarsh’s leadership, Primus has set a new standard for senior living excellence. With over 3,500 senior homes being developed across six South Indian metros, Adarsh aims to promote healthy lifestyles and holistic care for seniors nationwide. His dedication earned him the “Young Entrepreneur of the Year” award in 2018 and 2023 by ET. In 2024 Adarsh got two of the most sought-after investors,  General Catalyst and Nikhil Kamat to invest in Primus 
Beyond Primus, Adarsh is the managing partner of ReWild Retreats , offering uber-luxurious, nature-based weekend getaways in stunning locations.

Adarsh holds a Master’s degree in Construction Management from the University of Leeds, UK, and a degree in Industrial Engineering and Management from RV College of Engineering, Bangalore. He has served, on the board of Entrepreneurs Organization, Bengaluru, and as the past chairman for ASLI (Association of Senior Living India).

Amar Singh

A serial entrepreneur and seasoned executive with over twenty years of senior management and entrepreneurial experience in healthcare and software industries. Has worked in a spectrum of business environments from early stage companies (Clove, Simplexis, Amitive) to mid sized companies (i2, Bain&Co) and large companies (SAP, P&G).

Currently, is the founder and CEO of India's fastest growing chain of high-quality dental clinics. Healthcare in India lags behind WHO world averages and need for deploying good quality infrastructure is critical. Clove began operations in mid 2011 and as of November 2024 had over 550 dental centers offering all aspects of dental care to Indian consumers. Company is adding 90-120 centers every year as the infrastructure deployment tries to catch up to the need that exceeds 2500 new clinics every year (across India).

Also recognized leader in the cloud computing space having built one of the industry's leading and patented software application development platform (Amitive). In late 2010, GXS acquired Amitive's platform and migrated its entire application portfolio onto Amitive's platform. 

A change agent with proven experience building products and companies both inside a large company and outside. At SAP, he lead and built SAP's RFID business into one of its fastest growing business units. In addition as SVP of Supply Chain, Product Lifecyle Mgmt. and Manufacturing solutions, managed a team of over 500 professionals and lead one of SAP's product areas globally and helped grow the business. At Simplexis he built a leading public sector procurement technology company. A company he started with some Harvard Business School colleagues and Senator Lamar Alexander who remained chairman of the company until company was sold in 2002.

He enjoys traveling, golf, tennis and spending time with family. He can be reached directly at amar@amarsingh.org

---

 

Vikram Vuppala

Vikram Vuppala is Founder & CEO of India’s largest dialysis network - NephroPlus. After spending 10 years in the US healthcare industry, his passion to redefine healthcare delivery in India prompted him to found NephroPlus in 2010. He has expanded NephroPlus to Asia’s leading dialysis network of 385+ centers in 230 cities across 4 Countries. NephroPlus has rapidly grown under Vikram’s leadership to become 6th largest dialysis network in the world. He had raised more than $100 MM in 5 rounds of Private equity funding over last 10 years from Bessemer Venture Partners (BVP), IFC (World Bank VC arm), Investcorp and IIFL.

Vikram’s vision of enabling people on dialysis worldwide lead long, happy and productive lives has enabled NephroPlus to redefine dialysis care across 4 countries and has positioned itself well to disrupt several other regions across the World in the near future.

Prior to founding NephroPlus, Vikram was a strategy consultant at McKinsey in the US. Vikram with over two and half decades of global healthcare experience has helped various healthcare firms on strategic issues such as business development, growth strategy, portfolio rationalization, and M&A. Prior to McKinsey, he worked at Abbott Healthcare and ZS Associates.
 
He has been a speaker at numerous international entrepreneurial, healthcare and investment conferences. Vikram did his B.Tech. from IIT-Kharagpur, M.S. from The University of Illinois, Chicago and an MBA from Chicago Booth.

Mr. Vishal Bali

He was the Group CEO for Fortis Healthcare Limited. Mr Bali was also the CEO and MD of Wockhardt Hospitals, where he spearheaded its development from a single branch to one of the largest specialty hospital chains. He also led its merger with Fortis Healthcare. As a board member of leading healthcare organizations, he has been a part of the Strategic Initiatives Group of Joint Commission International, US, and the Global Agenda Healthcare Council of the World Economic Forum. His keenness in globalization of healthcare has also led to case studies at the Harvard Business School.

Babul Mody

Shiraz Bugwadia

Shiraz is a founding partner at o3 capital and has over 2 decades of extensive deal-making experience with a strong focus on the Healthcare and Lifesciences sectors. He has executed several deals worth billions of dollars and is one of the leading Investment Bankers in India.

He has been a keen observer and participant in the multi-fold expansion of India's Healthcare Landscape and has seen the industry grow and evolve to be a key driving force of the economy.

Before co-founding o3 Capital, Shiraz worked at Avendus Capital, where he was instrumental in setting up and leading their Healthcare and Lifesciences practice.

Shiraz holds an MBA degree from Melbourne Business School and is a B.E. Chemical graduate from Mumbai University.

Prasanna Bora

Prasanna heads the Lifesciences practice at o3 Capital. He has over 17 years of experience in investment banking and has closed multiple transactions across sectors with a special focus on Healthcare and Pharma. He has product expertise in Private Equity Syndication, M&A and Structured Credit.

Prior to o3 Capital, he has worked with HDFC Bank in their investment banking division.

Prasanna holds an MBA degree from IIM Kozhikode and completed his graduation from Mumbai University.

Swati Mehta

Swati has over 15 years of deal-making experience across Private Equity, Mergers & Acquisitions and Equity Capital Markets. She has concluded transactions aggregating to $1.6 Billion in Healthcare and related verticals.

Prior to joining o3 Capital, Swati has worked in the Investment Banking division of UBS, Equirus Capital and IDFC.

She is a Chartered Financial Analyst, (CFA Institute, USA), holds an MBA degree from Symbiosis University and is a graduate from Shri Ram College of Commerce.

Abhishek Kapoor

He completed his undergraduate from Simon Fraser University, Vancouver majoring in Finance and Human Resource. Post which Abhishek worked with PriceWater House Coopers, Ernst & Young, American Appraisal and Deloitte with the strategy consulting and merger and acquisition valuation practice. To hone his managerial skills, he went on to get his MBA from the prestigious Kellogg School of Management, Northwestern University, Chicago. Post his MBA he worked at Davita, the largest Kidney dialysis chain, in the United States, before returning to Kanpur to assist Regency in expanding and achieving its vision.

Ratan Jalan

Ratan is widely regarded as a rare thought leader in the healthcare industry. It was a strong urge to make a difference in healthcare that led him to set up Medium Healthcare Consulting.

At Medium, Ratan plays a pivotal role in shaping Medium’s philosophy with particular thrust on innovation, execution and patient-centricity. He is personally involved in each engagement often setting up near-impossible internal benchmarks. His thought-provoking writings and talks on a wide variety of subjects continue to inspire many in the field.

Before founding Medium Healthcare, Ratan was the CEO of Apollo Health and Lifestyle Limited, part of the Apollo Hospitals Group, for almost a decade. He created some of the most successful and innovative healthcare formats in the country such as a nationwide network of The Apollo Clinic and The Cradle, South Asia’s first boutique birthing centres. He also led the strategic marketing initiatives and international projects for the group.

In 1996 Ratan, as President, set up India’s first hospital architecture and consulting firm Asian Health Services, a JV with ServiceMaster, then a Fortune 500 company. In a short span of three years, the firm became the undisputed leader in the field and had served leading organizations like Wockhardt
Hospitals, Escorts Hospital, Max Healthcare, Aditya Birla Foundation, BLK Hospitals, IL&FS and Gleneagles Hospitals.

He has over four decades of experience across diverse industries and functional responsibilities. He started his professional career in the information technology industry with HCL and then moved to advertising at Lintas (now MullenLowe Lintas Group). During his ten years there, he led work for major
Indian and international brands.

Sukesh Chandra Gain

Dr. Karthik Narayan R

Dr. Karthik Narayan R is a distinguished healthcare leader with over 15 years of experience in geriatric care and hospital management. As the founder of Athulya Senior Care, he has revolutionized eldercare in India, combining clinical expertise with innovative management practices.

Dr. Amit Kakar

Dr. Amit Kakar joined Novo Holdings Asia in August 2020 as Head of Asia to lead investments and partnerships across the region, focusing primarily on the markets in China, Southeast Asia and India.  

Dr. Kakar has more than 25 years of healthcare experience with several senior management roles across the globe and having worked in India, China, Singapore, Denmark and the USA. 

His previous roles include Head of M&A and Business Development at Everlife Asia, Head of Healthcare Investments for Asia with the Avenue Capital Group, and various senior leadership positions with GE Healthcare.   

Dr. Kakar is a Medical Doctor with a postgraduate degree in Radiation and Nuclear Medicine from Tata Memorial Hospital and Cancer Centre in Mumbai, India. 

Gautam Khanna

Mr. Gautam Khanna boasts a 33-year career in leadership roles within the business sector. Presently, he serves as the CEO of P.D. Hinduja Hospital & Medical Research Centre, achieving global recognition in Newsweek World's Best Hospital Rankings. Simultaneously, he leads Hinduja College of Nursing and participates in the governing council of K P B Hinduja College of Commerce. His previous tenure of 22 years at 3M, a multinational conglomerate, saw him as the Executive Director and Country Business Leader for 3M Healthcare Businesses in South Asia. He is actively engaged in numerous Indian industry associations, including QCI (Quality Council of India), AOH (Association of Hospitals) Mumbai, Nathealth, and FICCI. With multiple accolades and affiliations, Mr. Khanna is an alumnus of IIT Kanpur and IIM Calcutta. 

Kshitij Vijayvargiya

Kshitij is a Managing Director and Partner in BCG's New Delhi office (India). Kshitij is part of BCG's Healthcare practice in India; and has ~14 years of experience in advising biopharma and healthcare companies across topics ranging from Strategy (business growth, portfolio, market entry, M&A), Sales and Marketing (brand launch, sales excellence, customer engagement) and Operations (Manufacturing, Procurement and Supply chain). He has also supported his clients on organization restructuring and culture transformations; and in embarking on digital enablement and transformations?

Prior to joining BCG, Kshitij has also set up a business unit for a tech enabled logistics company and grew it to a US$50M revenue within 2 years?

Some of Kshitij's recent experiences includes:?

India growth strategy for a global MNC pharmaco to grow 5-7X over 10 years through interventions across portfolio, customer segments, access to different coverage pools, market shaping and through initiatives on local partnerships and 'Make in India'?

• India strategy for a global specialty chemicals co. to grow 5x over 5 years through enhanced portfolio, supply chain and key account mgmt.?
• New product introduction and partnership strategy for a global MNC pharmaco to succeed in India?
• Launch strategy for an innovative product by an Indian company in the Diabetes space in India; covering target segments, value proposition, competitive positioning, doctor engagement, pricing and supply chain enablement?
• Business build strategy for an Indian Generics player to build a new Animal Health business in the US?
• Digital front end transformation for a large Indian pharma player – including initiatives around sales process automation and excellence, personalization of customer engagement and digital driven doctor and patient connect?
• Network strategy and plant consolidation for a large Indian pharma company; leading to savings of USD50+ M annually?
• Procurement transformation for a large Indian pharma company; leading to savings of 13% on covered base?
• Integrated transformation for a leading provider chain; incl. review and redesign of referral process, conversion of inbound leads, international patient management, case and revenue mix, ALOS optimization, cost optimization and growth plans?
• COVID response preparation in India: Strategy to strengthen COVID response infrastructure in India, epi model, build up of COVID care center, role of private sector hospitals in COVID management, capacity augmentation for nursing, consumables and testing?

Kshitij holds an MBA from the Indian Institute of Management, Calcutta and is a mechanical engineer?

Gunjan Singh

Gunjan Singh currently heads the Mature Markets (US, Europe, Canada, Mexico, CIS) Sales for Dr. Reddy’s. He also heads the Strategy and Product Management functions. Previously, he was the CEO at Wanbury Ltd., and prior to that, he headed the API Business at Jubilant Pharma and headed Sales and Marketing at Piramal Pharma Solutions. Before his foray into pharma, Gunjan worked as a strategy consultant with Accenture Consulting. He has managed portfolio, strategy, BD, sales and P&L in various capacities and has worked across APIs, formulations and CDMO.

Dr. Kunal Sehgal

Dr. Kunal Sehgal is a Hematopathologist and Flow Cytometrist and currently is Managing Director and Chief Pathologist, Neuberg Sehgal Pathlab. He received his M.D. in Pathology from PGIMER Chandigarh and was awarded the gold medal for the best student of the university during his course. He worked as a fellow and senior resident in the Hematopathology laboratory at Tata Memorial Hospital (TMH), Mumbai. He has been awarded the UICC ICRETT AUF Fellowship during which he worked at the flowcytometry laboratories at John Hopkins University, Baltimore and at Seattle Cancer Care Alliance, Seattle –USA. He also worked as a Consultant in the Hematology Laboratory at PD Hinduja National Hospital, Mumbai from 2011-2015. 

His main areas of interest are in the field of flow cytometry and newer parameters on CBC instruments. He has been actively involved in the development and standardization of six & eight color immunophenotyping at Hinduja Hospital and Tata Memorial Hospital. He has actively participated in various flowcytometry associated projects and training courses held at Hinduja and TMH and as part of the The Cytometry Society-India and INDO US conferences. He has presented papers at both national and international conferences. He is a certified NABL auditor for hematology and clinical pathology. He is a life member and Joint secretary of The Cytometry Society of India, and member of Mumbai Hematology Group and Indian Society of Hematology and Transfusion Medicine. 

Anant Kharad

Anant has over 11 years of Private Equity and M&A experience in the Healthcare and Life Sciences industry. At TH Healthcare & Life Sciences Anant leads the firm's M&A and private equity transactions for APAC and Middle East.

Dheeraj Jain

Dheeraj Jain, a successful entrepreneur and an early-stage investor with a strong sense of purpose and forward-thinking mindset. He founded Redcliffe Labs in 2018 with a clear vision in mind: to establish an affordable and technologically advanced diagnostics platform that spans across India, catering to the diverse needs of the population. Today Redcliffe Labs is a frontrunner being 4th largest consumer Diagnostics chain with 85+ labs operational in 250 cities, 2200 collection center and processing nearly 100K tests everyday. It has investments in excess of $100m from esteemed global impact-driven investors like Leapfrog, IFU, Healthquad, Chiratae, Schroders, Alkemi, etc who share the long-term vision of transforming Redcliffe Labs into an institution of excellence. As per the recent research presented at the 78th UN General Assembly, Redcliffe’s tests were up to 8 times more cost-effective than national treatment coverage for protecting against the consequences of cardiovascular disease, while its test for diabetes was less than 2/3 the cost of the cheapest comparable screening and telemedicine interventions. This affordable diagnosis delivered $400M in economic savings for India.

Dheeraj, a computer science graduate, started his career in 2001 as technology consulting in London with Zensar Technology. Subsequently, he joined Nokia in 2003 and spent 8 years gaining valuable experience across various key functions, also pursued his MBA at Cass Business School in London.

In 2011, he ventured into the leveraged buyout market consulting, operating out of London towards establishing an active mid-market leveraged buyout market. After returning back to India in 2015 he built an impressive early-stage investment portfolio comprising over 40 successful startups with nearly 15 exits till date. He wrote first cheque to several renowned companies, sat on their boards that earned him the distinction of being recognized as one of the most prolific angel investors of 2016 by the Economic Times. He was also co-founder for consumer electrical business, that he turnaround and sold to Firstcry’s Globalbees as one of the high quality D2C transaction in 2021.

During his journey, Dheeraj also co-founded the widely recognized women health brand 'PeeSafe,’ focusing on women's health, today its backed by publicly listed pharma company, Healthcare VC, etc. He also co-own Continua Kids that provides autism therapy across 35+ therapeutic clinics for conditions like Autism Spectrum Disorder, ADHD, Dyslexia, Down Syndrome, etc. He also chairs board of Crysta IVF, fastest growing IVF chain with six clinics operating clinics in tier 1 cities.

He was as a guest lecturer at City University London and was invited as esteemed speaker at a convention at Ross Business School, Michigan, USA. His impactful work across domains was acknowledged when he received the prestigious Bharat Gaurav Award in London in 2015, recognizing his noteworthy contributions, 40 under 40 Business world magazine as rare combination of success as an entrepreneur and investor.

Dr. Shravan Subramanyam

Dr Shravan Subramanyam, the former Managing Director of Wipro-GE Healthcare, leads the strategy and execution of Claypond Capital’s medical technology platform. The platform, which includes BPL Medical Technologies, will focus on medical equipment and digital solutions for the domestic and export market with an emphasis on localization and innovation.

Dr. Subramanyam is a physician from Madras Medical College with an MHA from Cornell University, with 20 years’ experience in life sciences & medical devices companies including Roche and Novartis, across geographies. He was previously the president of NATHEALTH (Healthcare Federation of India) and co-chair of Medical Technology for FICCI & CII.

See article: Dr Shravan Subramanyam Appointed to Lead Medical Technology Platform at Claypond Capital